Warrant [Member]
Class of Warrant or Right [Axis]
Restricted Stock Units [Member]
Award Type [Axis]
Stock Option Plan [Member]
Stock Option Plan [Member]
Warrant [Member]
Options Granted To Consultants [Member]
Mark Baum Chief Executive Officer [Member]
Title of Individual [Axis]
Consultant [Member]
Employees - Selling, General And Administrative [Member]
Related Party [Axis]
Employees - Research And Development [Member]
Directors - Selling, General And Administrative [Member]
Director - Selling And Adminstrative [Member]
Consultants - Selling, General And Adminstrative [Member]
Consultants - Research And Development [Member]
Major Types of Debt and Equity Securities [Axis]
Range One [Member]
Exercise Price Range [Axis]
Stock Option 2 [Member]
Stock Option 3 [Member]
Stock Option 4 [Member]
Stock Option 5 [Member]
Options Granted To Employees [Member]
Tranche 1 CEO [Member]
Tranche 2 CEO [Member]
Tranche 3 CEO [Member]
Tranche 4 CEO [Member]
Tranche 5 CEO [Member]
Consultant Tranche 1 [Member]
Consultant Tranche 2 [Member]
Consultant Tranche 3 [Member]
Consultant Tranche 4 [Member]
Consultant Tranche 5 [Member]
DermaStar [Member]
April PPM [Member]
Underwriter Warrants [member]
IR Consultant [Member]
Minimum [Member]
Range [Axis]
Maximum [Member]
Stock Option Two [Member]
Stock Option Three [Member]
Dr. Robert J. Kammer [Member]
Dr.Balbir Brar [Member]
Consultant Two [Member]
450,000 Restricted Stock [Member]
600,000 Restricted Stock [Member]
100,000 Restricted Stock [Member]
Range Two [Member]
Range Three [Member]
Range Four [Member]
Range Five [Member]
Tranche 1 CEO [Member]
Tranche 2 CEO [Member]
Tranche 3 CEO [Member]
Consultant Tranche 1 [Member]
Consultant Tranche 2 [Member]
Consultant Tranche 3 [Member]
Consultant Tranche 4 [Member]
Consultant Tranche 5 [Member]
IR Consultant 1 [Member]
IR Consultant 2 [Member]
Paul Finnegan [Member]
Subsequent Event [Member]
Subsequent Event Type [Axis]
Peter Kenny [Member]
Restricted Shares [Member]
Preferred Stock [Member]
Equity Components [Axis]
Common Stock [Member]
Additional Paid-In Capital [Member]
Deficit Accumulated During The Development Stage [Member]
2007 Notes [Member]
Debt Instrument [Axis]
Mr. Ladonnikov [Member]
Consulting Agreement [Member]
Products and Services [Axis]
Consulting Agreement One [Member]
Consulting Agreement Two [Member]
John N Bonfiglio [Member]
Series A Convertible Preferred Stock [Member]
Class of Stock [Axis]
Series A Preferred Stock [Member]
Restricted Stock Units One [Member]
Contingencies One [Member]
Contingencies Two [Member]
Document And Entity Information
Entity Registrant Name
Entity Central Index Key
Document Type
Document Period End Date
Amendment Flag
Current Fiscal Year End Date
Entity Voluntary Filers
Entity Well-KnownSeasoned Issuer
Entity Current Reporting Status
Entity Filer Category
Entity Public Float
Entity Common Stock, Shares Outstanding
Document Fiscal Period Focus
Document Fiscal Year Focus
Statement of Financial Position [Abstract]
ASSETS
Current assets
Cash and cash equivalents
Restricted short-term investment
Prepaid expenses and other current assets
Deferred offering costs
Total current assets
Furniture and equipment, net
TOTAL ASSETS
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities
Accounts payable and accrued expenses
Accrued payroll and related liabilities
Total current liabilities
Commitments and contingencies
STOCKHOLDERS' EQUITY
Common stock, $0.001 par value, 395,000,000 shares authorized, 8,970,364 and 6,772,066 shares issued and outstanding at December 31, 2013 and December 31, 2012, respectively
Additional paid-in capital
Deficit accumulated during the development stage
TOTAL STOCKHOLDERS' EQUITY
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY
Common stock, par value
Common stock, authorized shares
Common stock, issued shares
Common stock, outstanding shares
Income Statement [Abstract]
Revenues:
License revenues
Operating Expenses:
Selling, general and administrative
Research and development
Loss from operations
Other income (expense):
Interest expense
Interest income
Loss on extinguishment of debt
Gain on settlement
Gain on forgiveness of liabilities
Total other income (expense), net
Net loss
Deemed dividend to preferred stockholders
Net loss attributable to common stockholders
Net loss attributable to common stockholders per share of common stock, basic and diluted:
Weighted average number of shares of common stock outstanding, basic and diluted
Statement [Table]
Statement [Line Items]
Balance
Balance, share
Estimated fair value of services contributed by stockholders
Issuance of common stock at $0.256 per share in May and June 2000
Issuance of common stock at $0.256 per share in May and June 2000, shares
Capital contributions
Issuance of common stock at $0.256 per share in August 2005
Issuance of common stock at $0.256 per share in August 2005, shares
Exercise of stock options at $0.256 per share in August 2005
Exercise of stock options at $0.256 per share in August 2005, shares
Exercise of stock options at $0.256 per share in June and July 2006
Exercise of stock options at $0.256 per share in June and July 2006, shares
Issuance of common stock at $0.256 per share during January and March 2007
Issuance of common stock at $0.256 per share during January and March 2007, shares
Exercise of stock options and warrants at $0.256 per share in April and August 2007
Exercise of stock options and warrants at $0.256 per share in April and August 2007
Forgiveness of notes payable and interest
Issuance of restricted common stock at $80.00 per share in August 2007
Issuance of restricted common stock at $80.00 per share in August 2007, shares
Issuance of common stock in connection with merger on September 17, 2007
Issuance of common stock in connection with merger on September 17, 2007, shares
Net proceeds from private placement offering issued at $100,000 per unit in September and October 2007
Net proceeds from private placement offering issued at $100,000 per unit in September and October 2007, shares
Issuance of common stock related to conversion of senior convertible notes payable and accrued interest
Issuance of common stock related to conversion of senior convertible notes payable and accrued interest, shares
Beneficial conversion feature upon conversion of senior convertible notes payable
Issuance of common stock and warrants for consulting services in September 2007 at a value of $80.00 per share for stock transaction and $100,000 per unit for stock and warrant transaction
Issuance of common stock and warrants for consulting services in September 2007 at a value of $80.00 per share for stock transaction and $100,000 per unit for stock and warrant transaction, shares
Stock-based compensation
Net proceeds from private placement offering issued at $110,000 per unit in May 2008 and final costs of 2007 private placement offering
Net proceeds from private placement offering issued at $110,000 per unit in May 2008 and final costs of 2007 private placement offering, shares
Adjustment and issuance of common stock, warrant and stock options related to consulting services agreement
Adjustment and issuance of common stock, warrant and stock options related to consulting services agreement, shares
Issuance of restricted stock at $28.00 per share in November 2008
Issuance of restricted stock at $28.00 per share in November 2008, shares
Issuance of common stock and stock options related to consulting agreements
Issuance of common stock and stock options related to consulting agreements, shares
Exercise of stock options at $39.60 per share August 2009
Exercise of stock options at $39.60 per share August 2009, shares
Issuance of restricted stock at $32.00 per share in October 2010
Issuance of restricted stock at $32.00 per share in October 2010, shares
Forfeiture of unvested restricted stock in May 2011
Forfeiture of unvested restricted stock in May 2011, shares
Issuance of Series A Preferred Stock at $10,000 per share in December 2011
Issuance of Series A Preferred Stock at $10,000 per share in December 2011, shares
Preferred stock beneficial conversion feature
Accretion of preferred stock discount
Estimated fair value of stock options granted to former employees in forgiveness of liabilities
Loss from modification and extinguishment of debt
Conversion of convertible note at $0.68 per common share in February 2012
Conversion of convertible note at $0.68 per common share in February 2012, shares
Round lot adjustment for reverse stock split, February 2012
Round lot adjustment for reverse stock split, February 2012, shares
Line of Credit conversion in April 2012 into common stock and warrant units at $3.95 per unit
Line of Credit conversion in April 2012 into common stock and warrant units at $3.95 per unit, shares
April Private Placement, issuance of common stock and warrant units at $3.95 per unit, net of costs, in April 2012
April Private Placement, issuance of common stock and warrant units at $3.95 per unit, net of costs, in April 2012, shares
Series A Preferred Stock conversion in June 2012
Series A Preferred Stock conversion in June 2012, shares
PCCA Purchase Agreement, sale of common stock at $4.80 per share, net of costs, in August 2012
PCCA Purchase Agreement, sale of common stock at $4.80 per share, net of costs, in August 2012, shares
Exercise of stock options
Exercise of stock options, shares
Cancelled common stock at $5.25 per share related to reverse stock split, February 2013
Cancelled common stock at $5.25 per share related to reverse stock split, February 2013, shares
Public offering of common stock at $5.25 per share, net of costs of $596,281, in February and March 2013
Public offering of common stock at $5.25 per share, net of costs of $596,281, in February and March 2013, shares
Cashless exercise of stock options
Cashless exercise of stock options, shares
Issuance of common stock upon vesting of RSUs
Issuance of common stock upon vesting of RSUs, shares
Stock-based compensation
Stock-based compensation, shares
Net loss
Balance
Balance, share
Statement of Stockholders' Equity [Abstract]
Equity price per share
Exercise of stock option price per share
Exercise of stock options and warrants price per share
Issuance of restricted common stock price per share
Issuance share to private placement offering at per unt
Issuance of common stock and warrants for consulting services per share
Issuance of common stock and warrants for consulting services per unit
Conversion of convertible price per share
Line of credit conversion price per share
Issuance of common stock for public offering price per share
Sale of common stock price per share
Cancelled common stock price per share
Proceeds from public offering cost
Statement of Cash Flows [Abstract]
CASH FLOWS FROM OPERATING ACTIVITIES
Adjustments to reconcile net loss to net cash used in operating activities:
Estimated fair value of contributed services
Gain on forgiveness of liabilities
Amortization of prepaid consulting fees
Depreciation
Loss on extinguishment of debt
Non-cash interest on notes payable
Stock-based compensation
Payments made on behalf of Company by related party
Changes in assets and liabilities:
Prepaid expenses and other current assets
Accounts payable and accrued expenses
Accrued payroll and related liabilities
Deferred revenue
NET CASH USED IN OPERATING ACTIVITIES
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of restricted short-term investment
Purchases of furniture and equipment
NET CASH USED IN INVESTING ACTIVITIES
CASH FLOWS FROM FINANCING ACTIVITIES
Payments for cancelled common stock
Proceeds from issuance of notes payable to a related party
Proceeds received in connection with debt modification
Proceeds from issuance of preferred stock
Proceeds from notes payable
Preferred stock deemed dividend paid at conversion
Cash advances from related party
Repayment of advances from related party
Net proceeds from purchase of common stock and exercise of warrants and stock options
Proceeds from issuance of common stock and warrants for cash, net of offering costs
NET CASH PROVIDED BY FINANCING ACTIVITIES
NET CHANGE IN CASH AND CASH EQUIVALENTS
CASH AND CASH EQUIVALENTS, beginning of period
CASH AND CASH EQUIVALENTS, end of period
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Cash paid for income taxes
SUPPLEMENTAL DISCLOSURES OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
Issuance of and adjustment to common stock and warrants to consulting firms for prepaid consulting fees
Deferred offering costs in connection with equity offering recorded in account payable
Conversion of related party accounts payable into common stock
Conversion of notes payable and accrued interest into common stock
Forgiveness of notes payable and accrued interest to shareholders
Conversion of advances to notes payable to shareholders
Related party acquisition of Phase 3 liabilities
Conversion of preferred stock into common stock
Reclassification of deferred offering costs to additional paid-in capital in connection with equity offering
Issuance of common stock for consulting services previously included in accounts payable and accrued expenses
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization
Accounting Policies [Abstract]
Summary of Significant Accounting Policies
Restricted Short-Term Investment
Restricted Short-Term Investment
Debt Disclosure [Abstract]
Accounts Payable and Accrued Expenses
Notes Payable
Equity [Abstract]
Stockholders' Equity
Income Tax Disclosure [Abstract]
Income Taxes
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies
Subsequent Events [Abstract]
Subsequent Events
Basis of Presentation
Principles of Consolidation
Development Stage Enterprise
Research and Development
Intellectual Property
Revenue Recognition and Deferred Revenue
Income Taxes
Cash and Cash Equivalents
Concentrations of Credit Risk
Deferred Offering Costs
Furniture and Equipment
Deferred Rent
Fair Value Measurements
Beneficial Conversion Features and Debt Discounts
Stock-Based Compensation
Basic and Diluted Loss per Common Share
Use of Estimates
Reclassifications
Recently Adopted Accounting Pronouncements
Recently Announced Accounting Pronouncements
Schedule of Stock Based Compensation and Equity Instruments
Schedule of Basic and Diluted Earnings Per Common Share
Schedule of Accounts Payable and Accrued Expenses
Schedule of Stock Option Plan Activity
Schedule of Fair Value Assumption
Schedule of Shares Outstanding and Exercisable
Market Based Vesting Conditions for Restricted Stock Units Granted
Schedule of Restricted Stock Units Activity
Schedule of Warrants Activity
Schedule of Warrants Issued
Schedule of Warrants Outstanding and Warrants Exercisable
Schedule of Provision for Income Taxes
Schedule of Income Tax Reconciliation
Schedule of Deferred Tax Assets and Liabilities
Schedule of Future Payments Under Leases
Accumulated deficit during development stage
Revenue
Additional royalty payments based on percent of net sales
Deposit coverage limits by FDIC
Cash deposits in excess of FDIC limits
Unrecognized tax benefits
Depreciation expense
Common stock equivalents, dilutive instruments
Compensation Expenses
Numerator - net loss attributable to common stockholders
Denominator - weighted average number of shares outstanding, basic and diluted
Net loss per share, basic and diluted
Restricted Short-Term Investment Details Narrative
Certificate of deposit
Restricted common stock underlying the stock-based compensation accrual
Stock-based compensation related to restricted common stock issuances and accruals
Accounts payable
Accrued offering costs
Deferred rent
Other accrued expenses
Stock-based compensation accrual
Total accounts payable and accrued expenses
Proceeds form issuance of convertible notes
Notes bearing interest rate
Warrants issued to exercise common stock
Interest expense on notes
Notes maturity date
Common stock conversion price per share
Common stock issued in result of notes
Debt discount amortized
Convertible notes
Percentage of notes acquired
Accounts payable
Accrued interest
Proceeds from conversion agreement
Stock issued in payment of notes
Stock issued in payment of notes, shares
Percentage of ownership of the notes
Note principal balance
Proceeds form line of credit
Line of Credit
Common stock issued during the period
Warrants exercise price per share
Discount rate
Expected warrant life
Expected volatility rate
Expected dividends
Capital stock, shares authorized
Common stock, shares authorized
capital contributions
Common stock issued shares
Proceeds form common stock
Common stock price per share
Additional capital contributions in cash
Capital contribution received from shareholders
Shares issued upon exercise of stock options
Shares issued upon warrants exercise
Additional paid in capital
Restricted stock shares granted to an executive
Common stock, shares outstanding
Common stock sold at private placement, shares
Net proceeds from private placement
Gross proceeds form issuance of private placement
Warrant issued to purchase number of common stock
Warrants exercise price
Placement agent fees and other related expenses
Stock issued in conversion of debt
Stock issued in conversion of debt, shares
Debt discount
Fair value of warrants
Number of shares, options cancelled/forfeit
Shares, options cancelled/forteited value
Decrease value of additional paid in capital and consulting expense
Common stock shares issued for services
Common stock issued for services
Expense charged to additional paid in capital
Stock issued during period, value
Option issue to purchase number of common stock
Stock options exercise price
Fair value of Black-Scholes Merton pricing model
Stock-based compensation for stock options
Number of shares, options granted
Granted restricted stock units
Percentage of option and restricted stock vested immediately
Restricted stock, per share
Restricted stock vested immediately
Number of stock returned to treasury and cancelled
Convertible debt
Common stock issued settle cashless exercise provision, shares
Payment made on cancellation of common stock
Payment made on cancellation of common stock, shares
Number of underwritten public offering common stock shares closed
Proceeds from public offerings
Additional shares purchased by underwriters
Net cash proceeds from the exercise of the over-allotment option
Stock issued during period value issued to underwriters
Underwriting agreement description
Preferred stock, authorized shares
Preferred stock, par value
Preferred stock, shares issued
Preferred stock, shares outstanding
Conversion price per share
Liquidation preference, per share
Aggregare purchase price
Number of stock converted into preferred stock
Preferred stock dividend
Number of stock converted
Aggregate number of shares
Common stock available for future issuance
Closing price of common stock
Weighted-average remaining vesting period
Percentage of forfeiture of stock option grants to employees and directors
Unrecognized compensation expense related to unvested stock options
Restricted stock units issued
Restricted stock vest in future
Target ranging price
Granted restricted stock units per person
Number of granted restricted stock units agreed to cancel
Fair value of restricted stock units
Unrecognized compensation expense related to restricted stock units
Simulation period
Volatility rate
Risk free interest rate
Stock option vesting period description
Remeasured fair value of restricted stock units
Number of restricted stock, forfeited
Warrants expire
Warrants vesting period description
Number of shares, Outstanding, Beginning balance
Number of shares, Options granted
Number of shares, Options exercised
Number of shares, Options cancelled/forfeit
Number of shares, Outstanding, Ending balance
Number of shares, Options exercisable
Number of shares, Options vested and expected to vest
Weighted Avg. Exercise Price, Outstanding, Beginning balance
Weighted Avg. Exercise Price, Options granted
Weighted Avg. Exercise Price, Options exercised
Weighted Avg. Exercise Price, Options cancelled/forfeit
Weighted Avg. Exercise Price, Outstanding, Ending balance
Exercisable Ending Balance
Vested and expected to vest - end of period
Weighted Avg. Remaining Contractual Life, Options outstanding
Weighted Avg. Remaining Contractual Life, Options exercisable
Weighted Avg. Remaining Contractual Life, Options vested and expected to vest
Aggregate Intrinsic Value, Options outstanding
Aggregate Intrinsic Value, Options exercisable
Aggregate Intrinsic Value, Options vested and expected to vest
Weighted-average fair value of options granted
Expected terms (in years)
Expected volatility, minimum
Expected volatility, maximum
Risk-free interest rate, minimum
Risk-free interest rate, maximum
Dividend yield
Range of Exercise Prices, minimum
Range of Exercise Prices, maximum
Number of Options Outstanding
Weighted Average Remaining Contractual Life in Years
Weighted Average Exercise Price
Number Exercisable
Weighted Average Exercisable Exercise Price
Percentage of Number of Shares Granted
Number of Shares
Target Share Price
Number of RSUs, Outstanding, Beginning balance
Number of RSUs granted
Number of RSUs vested
Number of RSUs cancelled/forfeit
Number of RSUs, Outstanding, Ending balance
Weighted Average Grant Date Fair Value, Beginning balance
Weighted Average Grant Date Fair Value, RSUs granted
Weighted Average Grant Date Fair Value, RSUs vested
Weighted Average Grant Date Fair Value, RSUs cancelled/forfeit
Weighted Average Grant Date Fair Value, Ending balance
Number of shares, Outstanding, Beginning balance
Number of Shares Subject to Warrants Outstanding, Granted
Number of Shares Subject to Warrants Outstanding, Exercised
Number of Shares Subject to Warrants Outstanding, Expired
Number of shares, Outstanding, Ending balance
Weighted average remaining contractual life of the outstanding warrants in years
Weighted Avg. Exercise Price, Outstanding, Beginning balance
Weighted Avg. Exercise Price, Granted
Weighted Avg. Exercise Price, Exercised
Weighted Avg. Exercise Price, Expired
Weighted Avg. Exercise Price, Outstanding, Ending balance
Weighted-average fair value of awards granted
Expected terms
Dividend yield
Issue Date
Warrants Outstanding
Exercise Price
Warrants Exercisable
Expiration Date
Deferred tax asset valuation allowance
Federal net operating loss carryforwards
State net operating loss carryforwards
Federal net operating loss expiration date
State net operating loss expiration date
Federal research and development tax credits
State research and development tax credits
Federal research and development tax credits expiration date
Deferrerd tax asset
Deferrerd tax asset excess tax benefits
Federal
State
Total current
Federal
State
Change in valuation allowance
Total deferred
Income tax provision (benefit)
U.S. federal statutory tax rate
Benefit of lower tax brackets
State tax benefit, net
Research and development credits
Employee stock based compensation
Loss on debt conversion
Other
Valuation allowance
Effective income tax rate
NOL's
Depreciation and amortization
Other
Research & development credits
Deferred stock compensation
Unrealized gain or loss on investments
Total deferred tax assets
Valuation allowance
Net deferred tax assets
Lease agreement for office space (Square feet)
Operating lease Expiry
Operating lease, monthly rental
Operating lease, rent increase percentage
Rent expense
One time payment for acquire lease
Royalties range percentage
Maximum aggregate value of cash fees
2014
2015
2016
Total
Shares issued upon exercise of stock options
Payement of cash purchase price
Payment of cash to contigent
Minimum revenue for contingent payment
Contigent stock payment
Condition for contigent stock payment
Accrued offering costs
Additional royalty payments based on percent of net sales.
Amortization of prepaid consulting fees
April PPM
Restricted common stock underlying the stock-based compensation accrual
Common stock issued settle cash less exercise provision shares.
Consultant
Consultant Tranche 1
Consultant Tranche 2
Consultant Tranche 3
Consultant Tranche 4
Consultant Tranche 5
ConsultantsResearchAndDevelopment [Member]
Conversion of advances to notes payable to shareholders
Conversion of preferred stock into common stock
Conversion of related party accounts payable into common stock
Deferred Offering Costs
Deferred offering costs in connection with equity offering recorded in account payable
DermaStar
Development Stage Enterprise
Dilutive instruments.
DirectorSellingAndAdminstrativeMember
Directors selling general and administrative [Member]
EmployeesResearchAndDevelopmentMember
Employees selling general and administrative [Member]
Estimated fair value of contributed services
Tranche 1 CEO
Tranche 2 CEO
Tranche 3 CEO
Tranche 4 CEO
Tranche 5 CEO
Forgiveness of notes payable and accrued interest to shareholders.
Gain on forgiveness of liabilities
IR Consultant
Issuance of and adjustment to common stock and warrants to consulting firms for prepaid consulting fees
Maximum deposit coverage limits.
New adopted accounting pronouncements policy [PolicyTextBlock].
Number Exercisable
Number of Shares
Number of underwritten public offering common stock shares closed.
Options granted to employees
Options granted to consultants
Other accrued expenses
Related party acquisition of Phase 3 liabilities
Percentage of Number of Shares Granted.
Preferred stock deemed dividend paid at conversion
Proceeds from issuance of notes payable to a related party
Proceeds received in connection with debt modification
Reclassification Of Deferred Offering CostsIn Connectionwit Equity Offering
Remeasured fair value of restricted stock units
Market-based vesting conditions for Restricted Stock Units Granted
Schedule Of Restrited Stock Units Activity
Schedule Of Warrants Activity
Schedule Of Warrants Issued
Schedule of Warrants Outstanding And Warrants Exercisable
Warrants Outstanding
Exercise Price
Vested
Weighted Average Exercisable Exercise Price
Warrants Exercisable
Stock issued during period shares issued to underwriters.
Stock issued during period value issued to underwriters.
StockOption2Member
StockOption3Member
StockOption4Member
StockOption5Member
StockOptionPlanMember
Stock-based compensation accrual
Target Share Price
Underwriter Warrants
Unrecognized compensation expense related to unvested stock options
Warrant
Stock Option Two [Member]
Stock Option Three [Member]
Consultant Two [Member]
Four Lakhs Fifty Thousand Restricted Stock [Member]
Six Lakhs Restricted Stock [Member]
One Lakh Restricted Stock [Member]
Underwriting Agreement Description
Closing Price Of Common Stock
Investment Options Exercise Price
Stock Option Vesting Period Description
Percentage Of Forfeiture Of Stock Option Grants
Target Ranging Price
Restricted Stock Units Granted During Period Per Person
Cancellation Of Restricted Stock Units During Period
Warrants Expired Duration
Warrants Vesting Period Description
Executive Restricted Stock Units Tranche One [Member]
Executive Restricted Stock Units Tranche Two [Member]
Executive Restricted Stock Units Tranche Three [Member]
Consultant Tranche One [Member]
Consultant Tranche Two [Member]
Consultant Tranche Three [Member]
Consultant Tranche Four [Member]
Consultant Tranche Five [Member]
Consultant One [Member]
Consultant Two [Member]
Royalties Range Percentage
Aggregate Value Of Cash Fees
Peter Kenny [Member]
Intellectual property [policy text block]
Consultants selling general and adminstrative [Member]
Restricted shares [member].
Range one [member].
Range two [member].
Range three [member].
Range four [member].
Range five [member]
Warrants issue date.
Warrants expiration date.
Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Exercisable Weighted Average Remaining Contractual Term
Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price
Share Based Compensation Arrangements By Share Based Payment Award Non Options Grants In Period Weighted Average Exercise Price
Share Based Compensation Arrangements By Share Based Payment Award Non Options Exercises In Period Weighted Average Exercise Price
Share Based Compensation Arrangements By Share Based Payment Award Non Options Expirations In Period Weighted Average Exercise Price
Adjustment To Additional Paid In Capital For Estimated Fair Value Of Services Contributed By Stockholders.
Stock Issued During Period Value New Issues One.
Stock Issued During Period Shares New Issues One.
Stock Issued During Period Value Stock Options Exercised One.
Stock Issued During Period Shares Stock Options Exercised One.
Stock Issued During Period Value New Issues Two.
Stock Issued During Period Shares New Issues Two.
Stock Issued During Period Value Stock Options Exercised Two.
Stock Issued During Period Shares Stock Options Exercised Two.
Stock Issued During Period Shares For Private Placement.
Stock And Warrants Issued During Period Shares For Services.
Stock Issued During Period Shares For Private Placement One.
Stock Issued During Period Value For Private Placement One.
Issuance Of Common Stock Warrant And Stock Options Value Related To Consulting Services Agreement.
Issuance Of Common Stock Warrant And Stock Options Shares Related To Consulting Services Agreement.
Stock Issued During Period Value Restericted Stock Awards Gross One.
Stock Issued During Period Shares Restericted Stock Awards Gross One.
Issuance Of Common Stock And Stock Options Value Related To Consulting Agreements One.
Issuance Of Common Stock And Stock Options Shares Related To Consulting Agreements Shares One.
Stock Issued During Period Value Stock Options Exercised Three.
Stock Issued During Period Shares Stock Options Exercised Three.
Stock Issued During Period Value Restericted Stock Awards Gross Two.
Stock Issued During Period Shares Restericted Stock Awards Gross Two.
Issuance Of Series A Preferred Stock Amount.
Issuance Of Series A Preferred Stock Shares.
Preferred Stock Beneficial Conversion Feature.
Estimated Fair Value Of Stock Options Granted To Former Employees In Forgiveness Of Liabilities.
Debt Conversion Converted Instrumet Amount Two.
Debt conversion Converted Instrument Shares Issued Two.
Debt Conversion Converted Instrumet Amount Three.
Debt conversion Converted Instrument Shares Issued Three.
Stock Issued During Period Value For Private Placement Two.
Stock Issued During Period Shares For Private Placement Two.
Pcca Purchase Agreement Sale Of Common Stock Net Of Offering Costs Amount.
Pcca Purchase Agreement Sale Of Common Stock Net Of Offering Costs Shares.
Stock Issued During Period Value Stock Options Exercised Four.
Stock Issued During Period Shares Stock Options Exercised Four.
Cancelled Common Stock Shares Related To Reverse Stock Split February 2013.
Cancelled Common Stock Shares Related To Reverse Stock Split February 2013 Shares.
Stock Issued During Period Value For Public Offering.
Stock Issued During Period Shares For Public Offering.
Cashless Exercise Of Stock Options.
Cash less Exercise Of Stock Options Shares.
Issuance Of Common Stock Upon Vesting Of Rsus Shares.
Loss From Modification And Extinguishment Of Debt.
Exercise Of Stock Options And Warrants Price Per Share.
Issuance Of Restricted Common Stock Price Per Share.
Issuance Share To Private Placement Offering At Per Unit.
Issuance Of Common Stock And Warrants For Consulting Services Per Share.
Issuance Of Common Stock And Warrants For Consulting Services Per Unit.
Conversion Of Convertible Price Per Share.
Sale Of Common Stock Price Per Share.
Cancelled Common Stock Price Per Share.
Beneficial Conversion Features And Debt Discounts [Policy Text Block].
Deferred Income Change In Valuation Allowance.
Effecticve Income Tax Rate Benefit Of Lower Tax Brackets.
Effective Income Tax Rate Loss On Debt Conversion.
Deferred Tax Assets Tax Acquired Net Operating Loss And Credit Carry Forwards.
Deferred Tax Asset Tax Credit carry Forwards Depreciation And Amortization.
Federal net operating loss expiration date.
State net operating loss expiration date.
Federal Research And Development Tax Credits.
State Research And Development Tax Credits.
Federal Research And Development Tax Credits Expiration Date.
Payement Of Cash Purchase Price.
Warrants Issued To Exercise Common Stock.
2007 Notes [Member].
Percentage Of Notes Acquired.
Mr Ladonnikov [Member].
Stock Issued During Period Value Issuance For Payment Of Notes.
Stock Issued During Period Shares Issuance For Payment Of Notes.
Percentage Of Ownership Of Notes.
Warrants Exercise Price Per Share.
Fair Value Assumptions Expected Discount Rate.
Additional Capital Contributions In Cash.
Stock Issued During Period Shares Warrants Exercised.
Stock Issued During Period Share Issued At Private Placement.
Gross Proceeds Form Issuance Of Private Placement.
Placement Agent Fees And Other Related Expenses.
Decrease Value Of Additional Paid In Capital And Consulting Expense.
Consulting Agreement [Member].
Expense Charged To Additional Paid In Capital.
Option Issue To Purchase Number Of Common Stock.
Fair Value Of Blackscholes Merton Pricing Model.
Consulting Agreement One [Member].
Consulting Agreement Two [Member].
John N Bonfiglio [Member].
Percentage Of Option And Restricted Stock Vested Immediately.
Restricted Stock Per Share.
Restricted Stock Vested Immediately.
Series A Convertible Preferred Stock [Member].
Aggregare Purchase Price.
Number Of Stock Converted Into Preferred Stock.
Aggregate Number Of Shares.
Restricted Stock Vest In Future.
Restricted Stock Units RSU One [Member].
Payment Of Cash To Contigent.
Minimum Revenue For Contingent Payment.
Contingencies One [Member].
Contingencies Two [Member].
Line of credit conversion price per share.
Issuance of common stock for public offering price per share.
Equity Option [Member]
WarrantActivityMember
ExecutiveRestrictedStockUnitsTrancheOneMember
ExecutiveRestrictedStockUnitsTrancheTwoMember
ExecutiveRestrictedStockUnitsTrancheThreeMember
ConsultantTrancheOneMember
ConsultantTrancheTwoMember
ConsultantTrancheThreeMember
ConsultantTrancheFourMember
ConsultantTrancheFiveMember
Assets, Current
Assets
Liabilities, Current
Development Stage Enterprise, Deficit Accumulated During Development Stage
Stockholders' Equity Attributable to Parent
Liabilities and Equity
Operating Income (Loss)
Interest Expense, Other
Other Nonoperating Expense
Preferred Stock Dividends and Other Adjustments
Shares, Outstanding
StockIssuedDuringPeriodSharesStockOptionsExercisedTwo
Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures
GainOnForgivenessOfLiabilities
Increase (Decrease) in Prepaid Expense and Other Assets
Increase (Decrease) in Accounts Payable and Accrued Liabilities
Increase (Decrease) in Employee Related Liabilities
Net Cash Provided by (Used in) Operating Activities
Payments to Acquire Property, Plant, and Equipment
Net Cash Provided by (Used in) Investing Activities
Payments for Repurchase of Common Stock
Repayments of Related Party Debt
Net Cash Provided by (Used in) Financing Activities
Cash and Cash Equivalents, Period Increase (Decrease)
Cash, Cash Equivalents, and Short-term Investments [Text Block]
Income Tax, Policy [Policy Text Block]
Accounts Payable and Accrued Liabilities
Accounts Payable, Current
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice
Fair Value Assumptions, Weighted Average Expected Dividend
Current Income Tax Expense (Benefit)
Deferred Federal Income Tax Expense (Benefit)
Deferred State and Local Income Tax Expense (Benefit)
Deferred Income Tax Expense (Benefit)
Income Tax Expense (Benefit)
Deferred Tax Assets, Tax Credit Carryforwards, Other
Deferred Tax Assets, Gross
Deferred Tax Assets, Valuation Allowance
Deferred Tax Assets, Net of Valuation Allowance
Operating Leases, Future Minimum Payments Due